BE799102A - Composes anesthesiques de la serie du pregnane et compositions en contenant, - Google Patents

Composes anesthesiques de la serie du pregnane et compositions en contenant,

Info

Publication number
BE799102A
BE799102A BE130749A BE130749A BE799102A BE 799102 A BE799102 A BE 799102A BE 130749 A BE130749 A BE 130749A BE 130749 A BE130749 A BE 130749A BE 799102 A BE799102 A BE 799102A
Authority
BE
Belgium
Prior art keywords
anesthesic
compounds
compositions containing
pregnane series
pregnane
Prior art date
Application number
BE130749A
Other languages
English (en)
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of BE799102A publication Critical patent/BE799102A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
BE130749A 1972-05-05 1973-05-04 Composes anesthesiques de la serie du pregnane et compositions en contenant, BE799102A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2114272A GB1430942A (en) 1972-05-05 1972-05-05 21-substituted 3alpha-hydroxy pregnanes

Publications (1)

Publication Number Publication Date
BE799102A true BE799102A (fr) 1973-11-05

Family

ID=10157915

Family Applications (1)

Application Number Title Priority Date Filing Date
BE130749A BE799102A (fr) 1972-05-05 1973-05-04 Composes anesthesiques de la serie du pregnane et compositions en contenant,

Country Status (16)

Country Link
JP (1) JPS4961150A (fr)
AT (1) AT355232B (fr)
AU (1) AU475168B2 (fr)
BE (1) BE799102A (fr)
CA (1) CA1013341A (fr)
CH (1) CH617710A5 (fr)
DE (1) DE2322532A1 (fr)
ES (1) ES414411A1 (fr)
FR (1) FR2183792B1 (fr)
GB (1) GB1430942A (fr)
IE (1) IE37596B1 (fr)
IL (1) IL42196A (fr)
LU (1) LU67546A1 (fr)
NL (1) NL7306234A (fr)
SE (1) SE400771B (fr)
ZA (1) ZA733035B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5939545A (en) * 1994-02-14 1999-08-17 Cocensys, Inc. Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
DK1038880T3 (da) * 1994-02-14 2008-03-03 Euro Celtique Sa Androstaner og pregnaner til allosterisk modulering af GABA-receptor
GR1003861B (el) * 2000-12-29 2002-04-11 Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa.
JP4915427B2 (ja) * 2009-03-30 2012-04-11 ブラザー工業株式会社 液体供給ジョイント、これを使用した液体吐出ヘッド及び記録装置
EP4717314A2 (fr) 2011-10-14 2026-04-01 Sage Therapeutics, LLC 3,3 composés de 19-nor-pregnane disubstitués, compositions et utilisations associées
SG10201606063RA (en) 2012-01-23 2016-09-29 Sage Therapeutics Inc Neuroactive steroid formulations and methods of treating cns disorders
RS62761B1 (sr) 2012-08-21 2022-01-31 Sage Therapeutics Inc Alopregnanolon za lečenje refraktornog epileptičkog statusa
CN117304245A (zh) 2013-04-17 2023-12-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
WO2014169836A1 (fr) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor-stéroïdes neuroactifs et procédés d'utilisation de ceux-ci
SMT202100509T1 (it) 2013-04-17 2021-11-12 Sage Therapeutics Inc Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia
CA2918735C (fr) 2013-07-19 2023-08-01 Sage Therapeutics, Inc. Steroides neuroactifs, compositions, et leurs utilisations
CN105579043B (zh) 2013-08-23 2021-09-14 萨奇治疗股份有限公司 神经活性类固醇、组合物和其用途
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
MY190408A (en) 2014-10-16 2022-04-21 Sage Therapeutics Inc Compositions and methods for treating cns disorders
US20170233433A1 (en) 2014-10-16 2017-08-17 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
WO2016082789A1 (fr) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions et procédés pour traiter des troubles du snc
LT3250210T (lt) 2015-01-26 2021-04-12 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti gydyti cns sutrikimus
DK3258939T3 (da) 2015-02-20 2022-12-12 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser heraf
PH12018501923B1 (en) 2016-03-08 2024-06-28 Sage Therapeutics Inc Neuroactive steroids, compositions, and uses thereof
CA3030420C (fr) 2016-07-11 2025-11-18 Sage Therapeutics, Inc. Steroides neuroactifs substitues en c7, c12 et c16 et methodes d'utilisation associees
WO2018013613A1 (fr) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
JP7670626B2 (ja) 2019-05-31 2025-04-30 セージ セラピューティクス， インコーポレイテッド 神経刺激性ステロイド及びその組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1346292A (fr) * 1962-09-14 1963-12-20 Roussel Uclaf Nouveau procédé de préparation des 21-amino stéroïdes
US3144446A (en) * 1963-12-20 1964-08-11 Upjohn Co Mono and bis nu-(3alpha, 17alpha-dihydroxy-11, 20-dioxo-5beta-pregnan-21-yl) quaternary ammonium salts of triethylenediamine

Also Published As

Publication number Publication date
NL7306234A (fr) 1973-11-07
FR2183792B1 (fr) 1977-07-15
CH617710A5 (en) 1980-06-13
AT355232B (de) 1980-02-25
CA1013341A (en) 1977-07-05
JPS4961150A (fr) 1974-06-13
DE2322532A1 (de) 1973-11-22
ZA733035B (en) 1974-04-24
AU5528473A (en) 1974-11-07
IE37596B1 (en) 1977-08-31
ATA395173A (de) 1979-07-15
SE400771B (sv) 1978-04-10
AU475168B2 (en) 1976-08-12
IE37596L (en) 1973-11-05
GB1430942A (en) 1976-04-07
ES414411A1 (es) 1976-02-01
IL42196A (en) 1978-10-31
IL42196A0 (en) 1973-07-30
FR2183792A1 (fr) 1973-12-21
LU67546A1 (fr) 1973-07-13

Similar Documents

Publication Publication Date Title
BE799433A (fr) Composes anesthesiques de la serie du pregnane et leur preparation
BE794482A (fr) Compositions photopolymerisables contenant des composes cis- alpha -dicarbonyliques cycliques et des sensibilisateurs choisis
IT995049B (it) Composizioni che generano gas
BE829837A (fr) Nouveaux derives du benzothiophene, leurs procedes de preparation ainsi que les compositions pharmaceutiques les contenant
BE797278R (fr) Compositions de polyether-polyurethane-polyuree et leurs applications
IL42196A (en) Anaesthetic steroids of the pregnane or norpregnane series
BE782105A (fr) Bis(2-pyridinethiol-1-oxyde) de phenylbismuth et compositions contenantce produit.
IT990931B (it) Migliorata struttura costruttiva di miscelatore
BE806457A (fr) Composition d'email semi-conducteur
IT1006584B (it) Composizioni insetticide
BE800311A (fr) Aminohalopyridines substituees, leur preparation et compositions en contenant
BE794067A (fr) Compositions desodorisantes et contre la transpiration
SE7506293L (sv) Farmaceutiska kompositioner for behandling av hyperkolesterolemi.
IL41752A0 (en) Novel steroids of the pregnane series,their manufacture and pharmaceutical compositions containing them
BR7300403D0 (pt) Composicao desodorizante
RO65953A (fr) Compositions explosifs
OA03710A (fr) Composition d'engrais.
BE803462A (fr) Composes steroides de la serie du pregnane, leur preparation et composition s en contenant
BR7302327D0 (pt) Composicoes de materias tanantes
BE795744A (fr) Compositions retardatrices d'inflammation
BE797215A (fr) Composition contenant de la protease
IL36127A0 (en) Novel esters of the pregnane series,their preparation and pharmaceutical compositions containing them
IL36608A0 (en) Halogenosteroids of the pregnane series,their manufacture and pharmaceutical compositions containing them
BE799101A (fr) Composes anesthesiques de la serie du pregnane et leur preparation
IL35790A0 (en) Novel steroids of the pregnane series,their preparation and pharmaceutical compositions containing them